Bluejay Diagnostics, Inc. (BJDX) vs Vivos Therapeutics, Inc. (VVOS)
- Bluejay Diagnostics, Inc. BJDX 2.35 +7.31%
- Vivos Therapeutics, Inc. VVOS 0.09 −10.00%
Bluejay Diagnostics, Inc. and Vivos Therapeutics, Inc. are both Medical Devices companies. Vivos Therapeutics, Inc. is the larger, with a market value of $3.2M against $2.6M — 1.2× the size. Bluejay Diagnostics, Inc. has the higher net margin (0.00% vs −121.8%) and the higher return on invested capital (0.00% vs −592.7%). Across the 13 metrics below, Bluejay Diagnostics, Inc. leads on 9 and Vivos Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | BJDX | VVOS | Medical Devices median |
|---|---|---|---|
| Gross margin | 0.00% | 61.89% | 57.76% |
| Operating margin | 0.00% | (107.89%) | (14.84%) |
| Net margin | 0.00% | (121.79%) | (14.45%) |
| Free cash flow margin | 0.00% | (90.97%) | (5.70%) |
| Return on equity | (98.89%) | 10,022.05% | (10.56%) |
| Return on assets | (81.07%) | (101.46%) | (17.26%) |
| Return on invested capital | 0.00% | (592.70%) | (5.22%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack